{"id":1089,"date":"2022-08-17T21:11:22","date_gmt":"2022-08-18T01:11:22","guid":{"rendered":"http:\/\/www.bu.edu\/imap\/?post_type=profile&#038;p=1089"},"modified":"2025-02-06T09:54:50","modified_gmt":"2025-02-06T14:54:50","slug":"nate-dalton","status":"publish","type":"profile","link":"https:\/\/www.bu.edu\/imap\/profiles\/nate-dalton\/","title":{"rendered":"Nate Dalton"},"content":{"rendered":"<h5>Founder of Daybreak Partners<br \/>\nCo-Founder, Former CEO, and Senior Advisor of Affiliated Managers Group<\/h5>\n<ul>\n<li>Expertise focused on the intersection of healthcare and technology.<\/li>\n<p><\/p>\n<li>Longtime experience with AMG, a global asset management company with approximately $700 billion in AUM.<\/li>\n<p><\/p>\n<li>Director of iCAD, Inc. (NASD: ICAD), a global leader in medical technology providing innovative cancer detection and therapy solutions.<\/li>\n<p><\/p>\n<li>Trustee of Boston University, serving on the Executive Committee and on the Investment Committee for its Endowment.<\/li>\n<p><\/p>\n<li>Board of Overseer of Scripps Research, the largest nonprofit biomedical research organization in the United States.<\/li>\n<\/ul>\n","protected":false},"author":18776,"template":"","_links":{"self":[{"href":"https:\/\/www.bu.edu\/imap\/wp-json\/wp\/v2\/profile\/1089"}],"collection":[{"href":"https:\/\/www.bu.edu\/imap\/wp-json\/wp\/v2\/profile"}],"about":[{"href":"https:\/\/www.bu.edu\/imap\/wp-json\/wp\/v2\/types\/profile"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/imap\/wp-json\/wp\/v2\/users\/18776"}],"version-history":[{"count":6,"href":"https:\/\/www.bu.edu\/imap\/wp-json\/wp\/v2\/profile\/1089\/revisions"}],"predecessor-version":[{"id":2418,"href":"https:\/\/www.bu.edu\/imap\/wp-json\/wp\/v2\/profile\/1089\/revisions\/2418"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/imap\/wp-json\/wp\/v2\/media?parent=1089"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}